162 related articles for article (PubMed ID: 31441730)
1. Assessment of Circulating Biomarkers in Relation to Various Stages of Diabetic Retinopathy in Type 2 Diabetic Patients-A Cross Sectional Study.
Mathala N; Akula A; Hegde S; Bitra R; Sachedev V
Curr Diabetes Rev; 2020; 16(4):402-409. PubMed ID: 31441730
[TBL] [Abstract][Full Text] [Related]
2. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
Koleva-Georgieva DN; Sivkova NP; Terzieva D
Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
[TBL] [Abstract][Full Text] [Related]
3. Correlation of various serum biomarkers with the severity of diabetic retinopathy.
Nalini M; Raghavulu BV; Annapurna A; Avinash P; Chandi V; Swathi N; Wasim
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S451-S454. PubMed ID: 28420575
[TBL] [Abstract][Full Text] [Related]
4. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
5. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
6. Cross Talk between Lipid Metabolism and Inflammatory Markers in Patients with Diabetic Retinopathy.
Crosby-Nwaobi R; Chatziralli I; Sergentanis T; Dew T; Forbes A; Sivaprasad S
J Diabetes Res; 2015; 2015():191382. PubMed ID: 26295054
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor-I in diabetic retinopathy.
Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
Gustavsson C; Agardh E; Bengtsson B; Agardh CD
J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
[TBL] [Abstract][Full Text] [Related]
9. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.
Ju HB; Zhang FX; Wang S; Song J; Cui T; Li LF; Zhang HY
Medicine (Baltimore); 2017 Aug; 96(31):e7671. PubMed ID: 28767589
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c.
Khaloo P; Qahremani R; Rabizadeh S; Omidi M; Rajab A; Heidari F; Farahmand G; Bitaraf M; Mirmiranpour H; Esteghamati A; Nakhjavani M
Endocrine; 2020 Sep; 69(3):536-541. PubMed ID: 32494901
[TBL] [Abstract][Full Text] [Related]
11. Enhanced circulating soluble LR11 in patients with diabetic retinopathy.
Takahashi M; Bujo H; Shiba T; Jiang M; Maeno T; Shirai K
Am J Ophthalmol; 2012 Jul; 154(1):187-92. PubMed ID: 22541650
[TBL] [Abstract][Full Text] [Related]
12. Association of Bone Metabolism Indices and Bone Mineral Density with Diabetic Retinopathy in Elderly Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Inpatient Study in China.
Zhao X; Huo L; Yu X; Zhang X
J Diabetes Res; 2021; 2021():8853622. PubMed ID: 33506053
[TBL] [Abstract][Full Text] [Related]
13. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
Sasongko MB; Wong TY; Jenkins AJ; Nguyen TT; Shaw JE; Wang JJ
Diabet Med; 2015 May; 32(5):686-91. PubMed ID: 25407692
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
Yu CG; Yuan SS; Yang LY; Ke J; Zhang LJ; Lang JN; Zhang DW; Zhao SZ; Zhao D; Feng YM
Am J Ophthalmol; 2018 Jul; 191():34-41. PubMed ID: 29621508
[TBL] [Abstract][Full Text] [Related]
15. Antimyeloperoxidase antibody is a biomarker for progression of diabetic retinopathy.
Sinha S; Saxena S; Das S; Prasad S; Bhasker SK; Mahdi AA; Kruzliak P
J Diabetes Complications; 2016; 30(4):700-4. PubMed ID: 26948921
[TBL] [Abstract][Full Text] [Related]
16. Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus.
Vinuthinee-Naidu MN; Zunaina E; Azreen-Redzal A; Nyi-Nyi N
BMC Ophthalmol; 2017 Jun; 17(1):91. PubMed ID: 28615022
[TBL] [Abstract][Full Text] [Related]
17. The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus.
Jongsareejit A; Potisat S; Krairittichai U; Sattaputh C; Arunratanachote W
J Med Assoc Thai; 2013 Nov; 96(11):1476-82. PubMed ID: 24428098
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy.
Huang EJ; Kuo WW; Chen YJ; Chen TH; Chang MH; Lu MC; Tzang BS; Hsu HH; Huang CY; Lee SD
Clin Chim Acta; 2006 Apr; 366(1-2):293-8. PubMed ID: 16343469
[TBL] [Abstract][Full Text] [Related]
19. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.
Tomić M; Ljubić S; Kastelan S
Coll Antropol; 2013 Apr; 37 Suppl 1():51-7. PubMed ID: 23837221
[TBL] [Abstract][Full Text] [Related]
20. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
